This work investigated the feasibility of dermal and transdermal delivery of doxycycline from vehicles containing Migliol 840 (M840) and ethanol. Delivery of the drug via the skin would provide a useful alternative to oral delivery, which has many undesirable side-effects: such as oesophageal ulceration and disturbance of the normal gut flora. Potential applications include malaria prophylaxis; and the treatment of acne vulgaris, Lyme disease and Reiter syndrome. Experiments were performed to determine the permeation of doxycycline across excised full-thickness human skin and heat-separated epidermal membranes from saturated solutions in ethanol, 1:1 and 2:1 ethanol/M840. Unusual burst behaviour was observed using an ethanol vehicle, possibly as a result of the formation of dimers at saturation. Doxycycline permeated to a higher degree from ethanolic vehicles when M840 is present. suggesting that M840 is capable of enhancing the permeation of doxycycline. The flux across full-thickness skill was highest from a 2:1 ethanol:M840 vehicle (2.41 mu g cm(-2) h(-1)), sufficient to deliver 282 mu g l(-1) using an area of application of 30 cm(2). The data also produced unexpected results in that permeability across heat separated skin was an order of magnitude greater than across full-thickness skin (28.75 mu g cm(-2) h(-1) for the 2:1 ethanol:M840 vehicle). Depth profiling indicated that the drug distributed quite evenly throughout the epidermis. The mean amount of doxycycline recovered from the epidermis at the end of a permeation experiment was 458.4 mu g ml(-1). This was far higher than the volume of extractable lipid present in the same unit area, approximately 52.3 mu g ml(-1) and indicated that a large proportion of the drug must have been located within the protein;lceous domain. The data therefore suggest (1) significant amounts of doxycycline call be administered into and a,across the skin; (2) M840 is a potentially useful enhancing vehicle, and (3) the transcellular route was of significance. (C) 1999 Elsevier Science B.V. All rights reserved.